Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118137) titled 'Memory Deterioration in Alzheimer Disease' on Aug. 4.
Study Type: Observational [Patient Registry]
Primary Sponsor: Norwegian University of Science and Technology
Condition:
Alzheimer Disease
Neurodegenerative Diseases
Magnetic Resonance Imaging
Memory Impairment
Intervention:
Device: 7T MRI
Device: EEG
Biological: Blood samples
Biological: Stool samples
Recruitment Status: Recruiting
Date of First Enrollment: October 15, 2023
Target Sample Size: 30
Countries of Recruitment:
Norway
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07118137
Published by HT Digital Content Services with permission...